Progenics Pharma Stock Price (NASDAQ:PGNX)

Add to My Stocks
$7.81 $0.08 (1.01%) PGNX stock closing price Aug 17, 2018 (Closing)
Prev Close* : $7.89
Market Cap:
Day Low: $7.75
52 Week Low: $5.01
Open: $7.91
Volume: -
Day High: $7.94
52 Week High: $9.42

Latest Stock Market News

Latest Articles

Progenics Pharma News - From Partners

PGNX Stockcharts

View PGNX PE ratio, PS ratio stocks charts and compare with peers.
PGNX Chart
Note: Compare Progenics Pharma stock price history with the index and industry peers.

Progenics Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Progenics Pharma Returns

(return on equity)

Progenics Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

PGNX Industry Peers

Company Price Change (%)
Skyepharma (SKYEY)6.280.02 (0.32%)
Adamas Pharma (ADMS)22.430.41 (1.8%)
Homology Medicn (FIXX)16.191.16 (6.69%)
Johnson & Johnson (JNJ)134.471.99 (1.5%)
Synergy Pharma (SGYP)1.830.01 (0.55%)
Ironwood Pharma (IRWD)18.280.02 (0.11%)
Merck (MRK)69.060.21 (0.31%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Supernus Pharma (SUPN)44.81.3 (2.99%)
Corium (CORI)8.930.24 (2.76%)
Mallinckrodt (MNK)34.690.55 (1.61%)
Dr. Reddy's Laboratories (RDY)33.830.52 (1.56%)
BAUSCH HEALTH (BHC)21.890.2 (0.92%)
Mylan (MYL)38.150.3 (0.79%)
Allergan (AGN)185.61.39 (0.75%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 18, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)22.430.41 (1.8%)
Progenics Pharma (PGNX)7.810.08 (1.01%)
Akorn (AKRX)18.990.16 (0.84%)
Teligent (TLGT)4.260.01 (0.23%)
Top losers from Medical-Generic Drugs industry
* As of Aug 18, 2018

Progenics Pharmaceuticals, Inc. Stock News - Partner Headlines

3 Hot Junior Biotech Plays   on Mar 16, 2018

Progenics Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues11.69M69.42M8.67M44.37M7.86M
Net Income-51.01M10.8M-39.11M4.41M-42.57M
Total Operating Expense70.08M56.31M47.97M41M49.89M
View Progenics Pharma income statement
balance sheet20172016201520142013
Total Assets145.95M198.98M131.25M161.03M114.54M
Total Liabilities82.5M94.22M40.59M36.12M35.56M
Shareholders Equity63.45M104.76M90.66M124.9M78.97M
View Progenics Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-6.22M-5.99M2.25M1.41M
Net Cash from (used by) Operating Activities-53.62M19.2M-40.13M13.72M-36.1M
Increase (Decrease) in Prop Plant And Equipment-0.23M-3.93M-0.32M-0.57M-
View Progenics Pharma cash flow statement

Progenics Pharma Stock Message Board

Progenics Pharma stock lost 1.01%, and the last close price as of Aug 17, 2018 is $7.81 for PGNX stock. Looking at Progenics Pharma market capitalization, which currently stands at $588.55M, we can say that PGNX stock is a Small Cap stock. A value investor must look at the fundamentals of a stock, and perform Progenics Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Progenics Pharma stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Progenics Pharma is worth a lot, it will most likely be reflected in an inflated Progenics Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 1,372,582 on the last trading day, as is evident from Progenics Pharma stock chart, and PGNX stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Progenics Pharma stock dividend was 0.00 during the last quarter. Progenics Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.